Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Preventice Services is a healthcare technology and cardiac diagnostics company focused on ambulatory electrocardiographic monitoring and remote patient monitoring for patients at risk of cardiac arrhythmias. Its best-known products include the BodyGuardian family of wearable remote cardiac monitors, supported by a cloud-based platform, AI-enabled analytics, and diagnostic monitoring services. The business historically operated under the Preventice brand and was acquired by Boston Scientific, which has since integrated the franchise into Boston Scientific Cardiac Diagnostics. Preventice's offerings are used by physicians to capture and analyze cardiac rhythm data through short- and long-term Holter monitoring, cardiac event monitoring, and mobile cardiac telemetry. The company is a commercial-stage medtech services business rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Preventice Services.